SCHEMBL2495022

SCHEMBL2495022

O=C1c2ccccc2C(=O)c2c1oc1cc(O)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 1/20 0.54
▸ NTRK1 P04629 1/20 0.54
▸ PLK3 Q9H4B4 1/20 0.54
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ KDM4E B2RXH2 4/20 0.52
▸ HSD17B10 Q99714 4/20 0.52
▸ ALOX15 P16050 3/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ CASP1 P29466 2/20 0.52
▸ CASP7 P55210 2/20 0.52
▸ TOP1 P11387 2/20 0.52
▸ MAOA P21397 2/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ TP53 P04637 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ ALDH1A1 P00352 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12766811 0.88 NTRK1 (0.54) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL7574891 0.81 NTRK1 (0.44) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL11768754 0.80 NTRK1 (0.74) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL30704422 0.80 NTRK1 (0.74) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL7570053 0.80 SOS1 (0.56) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL7571223 0.80 CYP19A1 (0.51) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL15950982 0.77 APP (0.61) MEN1KMT2AKDM4EHSD17B10ALOX15
SCHEMBL9840758 0.75 TOP1 (0.55) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL30397993 0.73 NTRK1 (0.64) TERTNTRK1PLK3MEN1KMT2A
SCHEMBL7572043 0.73 NTRK1 (0.51) TERTNTRK1PLK3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030296-B2 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase STERIX LIMITED (GB) 2011-10-04 — — US disclosed
US-20060281719-A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase LLOYD POTTER BARRY V 2006-12-14 — — US disclosed
US-7119081-B2 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase STERIX LIMITED (GB) 2006-10-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281719-A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase STS, SULT1E1, HSD17B11 TERT 764/4885NTRK1 4679/4885PLK3 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback